Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 47.4% on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares changed hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The company’s 50-day moving average price is C$0.08 and its 200-day moving average price is C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a market cap of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- What is the Australian Securities Exchange (ASX)
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
